• July 2020 – CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients (press release)

• September 2019 – Eligo Bioscience strengthens its leadership and development team (press release)

• May 2019 – Eligo has been selected by the European Commission as one of the top 1% Science Startups in Europe and received a €2.8M grant for the development of their lead candidate

• February 2019 – Eligo’s CEO is listed among the 100 influencers that will are transforming the French economy (La Tribune)

• October 2018 – Eligo is listed among the 10 startups shaping the future of Healthcare  (link)

• April 2018 – Eligo is a laureate of the Worldwide Innovation Challenge and grabs €1.8M in non-dilutive funding for its lead indication program

• September 2017 – Eligo secures $20M round of funding from Khosla Ventures & Seventure (press release)

• June 2017 – Eligo is selected as a 2017 Technology Pioneer by the World Economic Forum

• January 2017 – Xavier Duportet, Eligo’s CEO, is selected among the Forbes 30 Under 30 Europe in Science & Healthcare

• September 2016 – Eligo Bioscience is awarded two highly-selective grants by the French National Research Agency

• May 2016 – JP Lehner, former Chief Medical Officer at Sanofi, joins Eligo Bioscience’s Board of Directors

• July 2015 – Eligo closes a €2M seed-funding round with Seventure Partners

• February 2015 – Eligo is a laureate of the Tremplin Entreprises 2015 edition